Sirolimus-eluting stents to treat lesions with a high risk of restenosis. Six-month clinical follow-up in the first 100 patients;Stent liberador de rapamicina en el tratamiento de lesiones coronarias con alto riesgo de reestenosis. Sequimiento clínico a 6 meses de los primeros 100 pacientes

Revista Espanola de Cardiologia

Volumn 57, Issue 2, 2004, Pages 116-122

  de la Torre Hernández, José M ^a   Burgos, Virginia ^a   Gonzáles Enríquez, Susana ^a   Cobo, Manuel ^a   Zueco, Javier ^a   Figueroa, Álvaro ^a   Colman, Thierry ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Lesion; Restenosis; Stent

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; Q WAVE; RESTENOSIS; TREATMENT OUTCOME;

EID: 1642485741     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13057261     Document Type: Article

References (28)

1. Hernández JM, Goicolea J, Durán JM, Augé JM. Registro Español de Hemodinámica y Cardiología Intervencionista. XI informe oficial de la Sección de, Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (años 1990-2001). Rev Esp Cardiol 2002;55:1173-84.
2. Alonso JJ, Durán JM, Gimeno F, Ramos B, Serrador A, Fernández-Aviles F. Angioplastia coronaria en el paciente diabético. Situación actual y perspectivas futuras. Rev Esp Cardiol 2002; 55:185-200.
3. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schomig A. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999;83:1617-22.
4. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-9.
5. Doucet S, Schalig MJ, Vrolix MCM, Hilton D, Chenu P, De Bruyne B, et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001;104:2029-33.
6. Kastrati A, Schomig A, Dirschinger J, Mehilli J, Dotzer F, Von Weiser N, et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation 2000;102:2593-8.
7. Koning R, Eltchaninoff H, Commeau P, Khalife K, Gilard M, Lipiecki J, et al. Stent placement compared with balloon angioplasty for small coronary arteries: In hospital and 6-month clinical and angiographic results. Circulation 2001;104:1604-8.
8. Moer R, Myreng Y, Moldstad P, Albertsson P, Gunnes P, Lindvall B, et al. Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. J Am Coll Cardiol 2001;38:1598-603.
9. García E, Gómez-Recio M, Moreno R, Pasalodos J, Bethancourt A, Zueco J, et al. Stent reduces restenosis in small vessels. Results of the RAP study [abstract]. J Am Coll Cardiol 2001; 37(Suppl A):32-4.
10. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A, et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSOC trial. J Am Coll Cardiol 32;1998:90-6.
11. Buller CE, Dzavik V, Carere RG, Mancini GBJ, Barbeau G, Lazzam C, et al for the TOSCA investigators. Primary stenting versus balloon angioplasty in occluded coronary arteries. The total occlusion study of Canada TOSCA). Circulation 1999;100:236-42.
12. Sievert H, Rohde S, Utech A, Schulze R, Scherer D, Merle H, et al. Stent or angioplasty after recanalization of chronic coronary occlusions? The SARECCO trial. Am J Cardiol 1999;84:386-90.
13. Lotan C, Rozenman Y, Hendler A, Turgeman Y, Ayzenberg O, Beyar R, et al. Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. Eur Heart J 2000;21: 1960-6.
14. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, López-Minguez JR, et al for the RIBS study. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003;42:796-805.
15. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
16. 90Y beta-radiation versus placebo control for treatment of in stent restenosis. Circulation 2002;106:1090-6.
17. Fuster V. La rapamicina: Del laboratorio al tratamiento de las arterias en los pacientes. Rev Esp Cardiol 2003;56(Supl 1):2-6.
18. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al for the RAVEL study group. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
19. Moses J, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al, for the SIRIUS investigators. Sirolimus-eluting, stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
20. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I. Six and twelve month results from a randomized, double blind trial on a slow release paclitaxel eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
21. Degertekin M, Regar E, Tanabe K, Smits PC, Van der Giessen WJ, Carlier SG, et al. Sirolimus eluting stent for treatment of complex in stent restenosis: The first clinical experience. J Am Coll Cardiol 2003:41:184-9.
22. Tanabe K, Serruys PW, Grube F, Smits PC, Selbach G, Van der Giessen WJ, et al. TAXUS III. In stent restenosis treated with stent based delivery of paclitaxel incorporated in a slow release polymer formulation. Circulation 2003;107:559-64.
23. Lemos PA, Lee C, Degertekin M, Saia F, Tanabe K, Arampatzis CA, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. Insights from the Rapamycin Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2003;41:2093-9.
24. Saia F, Lemos PA, Lee C, Arampatzis CA, Hoye A, Degertekin M, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. A clinical and angiographic study. Circulation 2003;108:1927-9.
25. Holmes DR, Savage M Jr, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 2002;106: 1243-50.
26. Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ, Budaj A, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003;107:966-72.
27. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-33.
28. Steinhubl SR, Berger PB, Mann JT, Fry ETA, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 2002;288:2411-20.